Future is rising for Cialis
Patronizing Viagra can lead not only to a rise in the quality of the sexual lives of erectile dysfunction patients but it will also ultimately lead to a rise in the future of Cialis and Eli Lilly, the company that manufactures the drug. Cialis may not be the first erectile dysfunction drug approved by the United States Food and Drug Administration but it has managed to overtake Viagra’s sale in some markets.
Eli Lily is bullish about the growth of Cialis in the world market and it is even more confident that it will be able to get a greater share in the world market of erectile dysfunction drugs where Viagra reigns. This fearless forecast became almost a reality last year with Cialis generating sales of more than $1 billion during the first three quarters of last year. Eli Lilly is confident that this year will be a record breaking year considering that Cialis is now available in more than a hundred countries worldwide. Cialis has also dominated the market share in 20 of the 100 countries where it is being sold.
Cialis has clearly overtaken Viagra even if the latter has dominated the market for several years prior to the FDA approval of Cialis. Seeing Cialis on the top of the erectile dysfunction market may be an ambitious marketing forecast but it is slowly becoming a reality.
The introduction into the market of a new Cialis variant, the Cialis Once A Day is also expected to increase demand and sales of the product. The Daily Cialis is expected to attract a certain niche among men suffering from erectile dysfunction. However, the original Cialis is still way ahead of its competitors Viagra and Levitra since it works much longer even for as long as 36 hours for one dose. This has made Cialis a very popular drug in France where it is called “Le Weekend Pill”.
Leave a Reply
You must be logged in to post a comment.